First-line treatment with enfortumab vedotin and pembrolizumab provides durable benefits over chemotherapy in advanced urothelial carcinoma.

Neoadjuvant disitamab vedotin plus perioperative toripalimab has demonstrated efficacy in patients with HER2-expressing MIBC.

She turns heads when she enters places. Aside from her unique sense of style, she sports a daring hairstyle — a bald head — ...

What did you miss? Gladiators viewers seem unanimously against the rules of Unleash, which was introduced as a new sprinting ...

MASTERMIND is meant to be the toughest quiz on telly. But we have got hold of the application questions for the BBC show — which suggest you don’t have to be a complete brainbox to earn a seat in ...